Clinical Lymphoma, Myeloma & Leukemia

Editor(s): Jagannath, Sundar

Publisher: Elsevier

2019 Journal Impact Factor: 2.29 (Journal Citation Report, Web of Science Group)

ISSN: 2152-2650

Register for eToc Alerts


A peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma and myeloma.

This unique, focused journal is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma and myeloma.

Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.

Clinical Lymphoma, Myeloma & Leukemia was published as Clinical Lymphoma & Myeloma through December 2009.


Platform: Ovid
Publisher: Elsevier
Product Type: Journal
Author/Editor: Jagannath, Sundar
ISSN: 2152-2650
Internal Medicine
Language: English
Update Frequency: Monthly
Coverage: Vol 10 #1 (2010) - Present
Pdf Coverage: Vol 10 #1 (2010) - Present

2019 Journal Impact Factor: 2.29 (Journal Citation Report, Web of Science Group)